Seoul, South Korea

Seung Ki Lee

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 4.2

ph-index = 2

Forward Citations = 21(Granted Patents)


Company Filing History:


Years Active: 1998-2015

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Seung Ki Lee: Innovator in Pharmaceutical and Electronic Device Technologies

Introduction

Seung Ki Lee is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the fields of pharmaceuticals and electronic device technologies. With a total of 4 patents, his work focuses on innovative solutions for treating serious health conditions and enhancing electronic device performance.

Latest Patents

One of his latest patents involves a CDK-inhibiting pyrrolopyrimidine carboxamide derivative, which serves as a pharmaceutical composition for preventing or treating hepatocellular carcinoma. This invention is crucial as it relates to a compound that inhibits cell growth in liver cancer stem cells by targeting specific cyclin-dependent kinases (CDKs). Another notable patent describes a through substrate structure and electronic device package, detailing methods for manufacturing these components, which are essential for modern electronic devices.

Career Highlights

Seung Ki Lee has worked with various institutions, including Dankook University, where he has contributed to research and development in his fields of expertise. His innovative approaches have led to advancements that benefit both the medical and technological sectors.

Collaborations

Throughout his career, Seung Ki Lee has collaborated with notable colleagues, including Man Ki Park and Jeong Hill Park. These partnerships have fostered a collaborative environment that enhances the quality and impact of their research.

Conclusion

Seung Ki Lee's contributions to innovation in pharmaceuticals and electronic devices highlight his role as a key inventor in these fields. His patents reflect a commitment to advancing technology and improving health outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…